Cargando…
First Evidence of Kv3.1b Potassium Channel Subtype Expression during Neuronal Serotonergic 1C11 Cell Line Development
Kv3.1 channel is abundantly expressed in neurons and its dysfunction causes sleep loss, neurodegenerative diseases and depression. Fluoxetine, a serotonin selective reuptake inhibitor commonly used to treat depression, acts also on Kv3.1. To define the relationship between Kv3.1 and serotonin recept...
Autores principales: | Tabka, Hager, Cheikh, Amani, Maatoug, Sonia, Ayeb, Mohamed El, Bendahhou, Saïd, Benkhalifa, Rym |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583048/ https://www.ncbi.nlm.nih.gov/pubmed/33003279 http://dx.doi.org/10.3390/ijms21197175 |
Ejemplares similares
-
Cross Pharmacological, Biochemical and Computational Studies of a Human Kv3.1b Inhibitor from Androctonus australis Venom
por: Maatoug, Sonia, et al.
Publicado: (2021) -
Xenopus Oocyte’s Conductance for Bioactive Compounds Screening and Characterization
por: Cheikh, Amani, et al.
Publicado: (2019) -
Expression and Localization of Kv1.1 and Kv3.1b Potassium Channels in the Cochlear Nucleus and Inferior Colliculus after Long-Term Auditory Deafferentation
por: Poveda, Clara M., et al.
Publicado: (2020) -
Antidepressant drug paroxetine blocks the open pore of Kv3.1 potassium channel
por: Lee, Hyang Mi, et al.
Publicado: (2018) -
Studies of Conorfamide-Sr3 on Human Voltage-Gated Kv1 Potassium Channel Subtypes
por: López-Vera, Estuardo, et al.
Publicado: (2020)